Al-Shifa Trust held its first international research conference regarding the results of the Clinical Trial of the third and final phase of COVID-19.
Six hospitals were selected by the government for trials across the country and the Al-Shifa Trust Hospital Research Centre completed trials of a maximum of 2,700 volunteers.
Now, Pakistan has become a dependable country for clinical trials as its results were better than the other eight countries and it has become an important part of global research to combat the pandemic, experts said.
They noted that Pakistan turned the pandemic problem into an opportunity for research and according to the participants of the conference, now Pakistan is being studied as a model in dealing with COVID-19.
WHO Representative in Pakistan Dr. Palitha Mahipala said that Al-Shifa has helped the global effort against pandemic and noted that health and research facilities in Pakistan have rapidly transformed to cope with the challenge.
Chinese representative Miss Maria Song said that pharma companies are very encouraged by the response of Pakistani authorities as well as health and research facilities and the outcome of trials are also very promising.
Al-Shifa Trust President Major General Rehmat Khan (Retd) said, “I want to thank everyone who participated in our clinical trials.”
He said that in the beginning, we were in a state of fear and people were also scared but we accepted the challenge of clinical trials to play role in providing the best vaccine to the nation.
